Derivatives of quinoline-3-carboxanilide
    1.
    发明授权
    Derivatives of quinoline-3-carboxanilide 失效
    喹啉-3-甲酰苯胺的衍生物

    公开(公告)号:US5310913A

    公开(公告)日:1994-05-10

    申请号:US102393

    申请日:1993-08-05

    IPC分类号: C07D215/56

    CPC分类号: C07D215/56

    摘要: Compounds having formula ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6 and R.sup.7 are selected from the group consisting of hydrogen, hydroxy and methoxy. At most one of R.sup.1, R.sup.2 and R.sup.3 and at most one of R.sup.4, R.sup.5, R.sup.6 and R.sup.7 is selected from the group consisting of hydroxy and methoxy. M is selected from the group consisting of hydrogen and pharmaceutically acceptable inorganic or organic cations or tautomeric forms thereof. The compounds have immunomodulating activity.

    摘要翻译: 具有式“IMAGE”的化合物,其中R 1,R 2,R 3,R 4,R 5,R 6和R 7选自氢,羟基和甲氧基。 R 1,R 2和R 3中的至少一个以及R 4,R 5,R 6和R 7中至多一个选自羟基和甲氧基。 M选自氢和药学上可接受的无机或有机阳离子或其互变异构形式。 该化合物具有免疫调节活性。